» Articles » PMID: 31181442

LncRNA LINC00689 Promotes the Growth, Metastasis and Glycolysis of Glioma Cells by Targeting MiR-338-3p/PKM2 Axis

Overview
Date 2019 Jun 11
PMID 31181442
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Accumulating evidence supports that long non-coding RNAs (lncRNAs) are implicated in the tumorigenesis and progression of glioma. Recent studies find that lncRNA long intergenic non-protein coding RNA 689 (LINC00689) is associated with obesity and participates in eukaryotic gene expression. However, whether LINC00689 plays a critical role in glioma progression remains unknown. Here, we identified a highly expressed lncRNA LINC00689 in gliomas compared to normal brain tissues based on the GSE dataset (GSE4290). The analysis of our data indicated that the expression of LINC00689 was up-regulated in glioma tissues and cell lines. Moreover, the high expression of LINC00689 was closely correlated with tumor size ≥3 cm, high tumor grade, low KPS scores and poor prognosis of glioma patients. Further investigation demonstrated that LINC00689 knockdown markedly repressed the proliferation, migration, invasion and glycolysis of glioma cells. Additionally, silencing of LINC00689 significantly suppressed the growth of glioma cells in vivo. Mechanistically, LINC00689 functioned as a competing endogenous RNA (ceRNA) by directly interacting with miR-338-3p to promote pyruvate kinase M2 (PKM2) expression. Notably, we also revealed that restoration of PKM2 abolished the effects of LINC00689 silencing on glioma cell proliferation, migration, invasion and glycolysis. In summary, our results suggested that LINC00689/miR-338-3p/PKM2 axis might play an essential role in glioma progression.

Citing Articles

Silencing long non-coding RNA linc00689 suppresses the growth and invasion of osteosarcoma cells by targeting miR-129-5p/NUSAP1.

Zhang L, Song J, Xu X, Sun D, Huang H, Chen Y Int J Exp Pathol. 2025; 106(2):e12524.

PMID: 39891384 PMC: 11785588. DOI: 10.1111/iep.12524.


Effect of SNORD113-3/ADAR2 on glycolipid metabolism in glioblastoma via A-to-I editing of PHKA2.

Cui Z, Liu X, E T, Lin H, Wang D, Liu Y Cell Mol Biol Lett. 2025; 30(1):5.

PMID: 39794701 PMC: 11724473. DOI: 10.1186/s11658-024-00680-9.


Ailanthone disturbs cross-talk between cancer cells and tumor-associated macrophages via HIF1-α/LINC01956/FUS/β-catenin signaling pathway in glioblastoma.

Deng X, Zhang Q, Jin F, Lu F, Duan G, Han L Cancer Cell Int. 2024; 24(1):397.

PMID: 39639311 PMC: 11619249. DOI: 10.1186/s12935-024-03594-w.


Glucose metabolism in glioma: an emerging sight with ncRNAs.

Rong J, Wang Q, Li T, Qian J, Cheng J Cancer Cell Int. 2024; 24(1):316.

PMID: 39272133 PMC: 11395608. DOI: 10.1186/s12935-024-03499-8.


The pathogenesis mechanism and potential clinical value of lncRNA in gliomas.

Liu Y, Yuan H, Fan J, Wang H, Xie H, Wan J Discov Oncol. 2024; 15(1):266.

PMID: 38967893 PMC: 11226588. DOI: 10.1007/s12672-024-01144-4.